“同仁堂南极磷虾油”经销商回应成分造假风波：有专人在检测

Core Viewpoint - The recent controversy surrounding Tong Ren Tang's Antarctic krill oil product involves allegations of ingredient falsification, leading to significant scrutiny from consumer protection authorities and potential legal actions against the involved parties [1][2]. Group 1: Product Allegations - The product labeled as "Beijing Tong Ren Tang 99% High Purity Antarctic Krill Oil" was found to have a phospholipid content of 0, contradicting its claims [1]. - Anhui Habao Pharmaceutical Co., Ltd. admitted that it did not add the claimed "Antarctic krill oil" during production, raising concerns about intentional deception [2]. Group 2: Company Responses - Beijing Tong Ren Tang (Sichuan) Health Pharmaceutical Co., Ltd. stated that they are conducting product testing and will take responsibility for consumer purchases [1]. - The Shanghai Consumer Protection Committee has urged Beijing Tong Ren Tang (Sichuan) to conduct a self-examination, inform consumers accurately, and issue an apology [2]. Group 3: Legal and Regulatory Actions - The parent company, Beijing Tong Ren Tang Health Pharmaceutical Co., Ltd., has ordered the cessation of sales of the implicated product and initiated a full investigation [2]. - Legal proceedings have been initiated against the involved companies for unauthorized use of the "Beijing Tong Ren Tang" branding, which is considered illegal [2].